TrialClinical obesity2018

Improvements in health-related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity.

R L Kolotkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.